Related Experiment Video
Updated: Feb 13, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting autophagy for the treatment of cancer
Simone Fulda1,2,3
1Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, D-60528 Frankfurt, Germany.
Abstract:
Macroautophagy (herein termed autophagy) is evolutionarily highly conserved across eukaryotic cells and represents an intracellular catabolic process that targets damaged macromolecules and organelles for degradation. Autophagy is dysregulated in various human diseases including cancer. In addition, many drugs currently used for the treatment of cancer can engage autophagy, which typically promotes cancer cell survival by mitigating cellular stress. However, under certain circumstances activation of autophagy upon anticancer drug treatment can also trigger a lethal type of autophagy termed autophagic cell death (ACD). This may pave new avenues for exploiting the autophagic circuitry in oncology. This review presents the concept and some examples of anticancer drug-induced ACD.
Insights
Autophagy, a cellular recycling process, is often hijacked by cancer drugs to help cancer cells survive. However, it can also be triggered to cause cancer cell death, offering new therapeutic strategies.
Area of Science:
- Cellular Biology
- Oncology
- Molecular Mechanisms
Background:
- Macroautophagy (autophagy) is a conserved catabolic process in eukaryotic cells.
- Autophagy degrades damaged cellular components.
- Dysregulation of autophagy is implicated in human diseases, notably cancer.
Purpose of the Study:
- To review the concept of anticancer drug-induced autophagic cell death (ACD).
- To explore the dual role of autophagy in cancer therapy.
- To present examples of ACD triggered by anticancer drugs.
Main Methods:
- Literature review of scientific articles and studies.
- Analysis of the role of autophagy in cancer drug response.
- Identification and categorization of ACD-inducing anticancer agents.
Main Results:
- Anticancer drugs can activate autophagy, typically promoting cancer cell survival.
- Under specific conditions, autophagy activation leads to cancer cell death (ACD).
- ACD represents a distinct cell death pathway induced by certain chemotherapeutics.
Conclusions:
- Autophagy's role in cancer is complex, acting as both a survival and death mechanism.
- Targeting autophagy offers potential for novel cancer treatment strategies.
- Anticancer drug-induced ACD presents a promising avenue for cancer therapy development.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cancer
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

